全文获取类型
收费全文 | 2564篇 |
免费 | 232篇 |
国内免费 | 171篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 3篇 |
妇产科学 | 7篇 |
基础医学 | 211篇 |
口腔科学 | 38篇 |
临床医学 | 96篇 |
内科学 | 128篇 |
皮肤病学 | 8篇 |
神经病学 | 65篇 |
特种医学 | 87篇 |
外科学 | 108篇 |
综合类 | 411篇 |
预防医学 | 31篇 |
眼科学 | 32篇 |
药学 | 1377篇 |
中国医学 | 276篇 |
肿瘤学 | 87篇 |
出版年
2024年 | 7篇 |
2023年 | 11篇 |
2022年 | 43篇 |
2021年 | 80篇 |
2020年 | 53篇 |
2019年 | 35篇 |
2018年 | 45篇 |
2017年 | 62篇 |
2016年 | 79篇 |
2015年 | 69篇 |
2014年 | 120篇 |
2013年 | 356篇 |
2012年 | 164篇 |
2011年 | 197篇 |
2010年 | 139篇 |
2009年 | 133篇 |
2008年 | 118篇 |
2007年 | 126篇 |
2006年 | 131篇 |
2005年 | 163篇 |
2004年 | 113篇 |
2003年 | 73篇 |
2002年 | 61篇 |
2001年 | 59篇 |
2000年 | 65篇 |
1999年 | 50篇 |
1998年 | 40篇 |
1997年 | 35篇 |
1996年 | 34篇 |
1995年 | 34篇 |
1994年 | 30篇 |
1993年 | 37篇 |
1992年 | 26篇 |
1991年 | 19篇 |
1990年 | 21篇 |
1989年 | 21篇 |
1988年 | 16篇 |
1987年 | 17篇 |
1986年 | 6篇 |
1985年 | 8篇 |
1984年 | 13篇 |
1983年 | 8篇 |
1982年 | 12篇 |
1981年 | 15篇 |
1980年 | 7篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1972年 | 1篇 |
排序方式: 共有2967条查询结果,搜索用时 15 毫秒
1.
Biodegradable Polydioxanone Microspheres for Transcatheter Arterial Embolization: Proof of Principle
《Journal of vascular and interventional radiology : JVIR》2020,31(12):2132-2140.e5
PurposeTo evaluate feasibility, embolization success, biodegradability, reperfusion, and biocompatibility of biodegradable microspheres (MS) made from polydioxanone (PDO) for transcatheter arterial embolization.Materials and MethodsUnilateral selective renal embolization of a segmental artery was performed in 16 New Zealand White rabbits with PDO-MS (100–150 μm and 90–315 μm). Animals were randomly assigned to different observation periods and underwent control digital subtraction angiography (DSA) and MR imaging immediately (n = 3), 1 week (n = 2), 4 weeks (n = 2), 8 weeks (n = 2), 12 weeks (n = 5), and 16 weeks (n = 2) after embolization. Kidneys were harvested for macroscopic and histologic analysis of embolization success, biodegradability, and biocompatibility.ResultsEmbolization was technically successful in 15 of 16 animals. One animal died of anesthesia-related circulatory failure. The 100–150 μm MS were injected easily through 3-F catheters; the 90–315 μm MS tended to clog with intermittent catheter obstruction. DSA and MR imaging showed successful target embolization in 13 of 15 animals. In 2 animals, the entire kidney was affected owing to catheter clogging, including a reflux of MS while flushing. Control DSA and MR imaging showed increasing vascular reperfusion with time. Macroscopic and histologic analysis revealed necrosis/infarction in areas in which embolization was achieved. MS were extensively degraded after 16 weeks, and overall inflammatory reaction was mild.ConclusionsBiodegradable PDO-MS induced effective embolization of target vessels while demonstrating good biocompatibility. MS increasingly dissolved at 16 weeks, partial reperfusion started at week 1, and complete reperfusion started at week 8, thus offering possible advantages as a temporary embolic agent. 相似文献
2.
目的:探讨美托洛尔(β1受体阻滞剂)用于老年COPD合并冠心病史治疗的临床疗效。方法:选取2018年6月—2019年6月在我院接受治疗的60岁以上(包括60岁)COPD合并冠心病史老年患者,分为对照组与观察组。对照组给予接受布地奈德福莫特罗粉吸入剂治疗,观察组在使用布地奈德福莫特罗粉吸入剂治疗的基础上口服琥珀酸美托洛尔缓释片治疗,观察对比两组治疗效果。结果:观察组临床治疗效果优于对照组,观察组住院时长以及并发症的发生率低于对照组(P<0.05),差异具有统计学意义。结论:老年COPD合并冠心病史接受美托洛尔治疗,可有效缩短住院时长、用药效果明显、有效提升用药安全性,值得临床推广。 相似文献
3.
顺铂聚乳酸微球的药物释放特性及肝动脉栓塞研究 总被引:5,自引:0,他引:5
对顺铂聚乳酸微球进行了体外药物释放和家犬肝动脉栓塞研究。该微球粒径范围为50~200μm,平均粒径为115.76±35.94μm,顺铂含量为37.16%(W/W);体外药物释放机制符合Higuchi方程;肝动脉栓塞后8h,肝组织顺铂浓度高达21.55±12.18μg/g,明显高于肝动脉灌注顺铂组:3.16±0.09μg/g(P<0.05);肝动脉栓塞组的顺铂血浓峰值、各取血点浓度及曲线下面积AUC皆低于肝动脉灌注顺铂组。可望达到提高栓塞部位的药物疗效,降低全身毒副反应的作用。 相似文献
4.
Betlach Charles J. Arnold John D. Frost R. Wayne Leese Philip T. Gonzalez Mario A. 《Pharmaceutical research》1987,4(5):409-411
The bioavailability of a new sustained-release potassium chloride (KC1) tablet, designed for once-a-day dosing, was compared to a KC1 elixir using urinary excretion data. The study utilized 25 male volunteers dosed in a crossover design in a dietary/activity-controlled environment. The regimens consisted of a total of 80 mEq of potassium in three equally divided doses of elixir every 6 hr and a single 80-mEq dose using four 20-mEq sustained-release (SR) tablets. The mean time to maximum rate of potassium urinary excretion was 2.2 hr for the first elixir dose and 5.5 hr after the SR tablet (P < 0.01), thereby supporting the prolonged-release properties of this formulation. After correction for baseline urinary potassium excretion, the mean total 24-hr urinary potassium excretion was 42.18 mEq for the elixir and 40.41 mEq for the SR tablet. The results indicate that the absorption pattern from the SR tablet is equal to three doses of KC1 elixir dosed 6 hr apart. 相似文献
5.
Macrophages, dendritic cells or B lymphocytes have been shownto play a major role in the presentation of soluble antigensto CD4+ T cells. In contrast, the capacity of these cells topresent particulate antigens such as bacterial or parasiticantigens to T cells remains controversial. To investigate thisquestion, well defined particulate antigens were prepared bycovalent linkage of proteins or peptides to 1 µm in diametersynthetic microspheres. The T cell immunogenicity of such particulateantigens was analyzed in vitro and in vivo. In vitro, a solubleprotein such as hen egg lysozyme (HEL) coupled to beads stimulateda strong proliferative T cell response of lymph node cells fromHEL-primed mice or of specific T cell hybridomas. HEL coupledto beads was presented to the specific T cell hybridomas bysplenocytes or by peritoneal macrophages, but not by lymphomaB cells. Immunization of mice with several different proteinantigens or with a synthetic peptide covalently linked to beadsinduced strong CD4+ T cell responses in the absence of adjuvant.The strong in vivo immunogenicity of proteins coupled to beadsdid not result from a non-specific adjuvant effect of beadssince covalent linkage of the antigen to beads was strictlyrequired to induce T cell responses in the absence of adjuvant.In vivo treatment by carrageenan showed that macrophages arerequired for the in vivo stimulation of T cell responses bythese particulate antigens. Thus, these results demonstratedthe role of phagocytic cells, especially macrophages, for invivo presentation of particulate antigens. These particulateantigens represent an interesting approach for the developmentof new vaccines, and for the in vivo analysis of the role ofvarious antigen presenting cells in T cell activation and differentiation. 相似文献
6.
目的 制备甘草蛋白免疫磁性微球,并建立快速、精确的免疫磁性捕获ELISA法检测甘草蛋白。方法 采用种子聚合法合成聚苯乙烯磁性微球,并以兔抗甘草蛋白IgG抗体致敏,制备特异性捕获甘草特征蛋白的免疫磁性微球。以生物素标记抗体为示踪抗体,结合辣根过氧化物酶标亲和素建立ELISA检测系统,用于甘草药材和含甘草中成药中甘草蛋白的分析。结果 利用该方法对甘草药材和中成药中甘草蛋白抗原检测,检测灵敏度达到10ng/mL。结论 免疫磁性捕获ELISA检测技术方便、快速、准确,为生药的品种鉴定及中成药的质量控制提供一种新方法。 相似文献
7.
蜂毒素微球经动脉介入治疗大鼠肝癌的实验研究 总被引:9,自引:0,他引:9
目的:观察蜂毒素微球(M-MS)经动脉介入对大鼠肝癌的治疗作用.方法:采用改良的复乳-液中干燥法制备蜂毒素-聚乳酸/羟乙酸微球,建立大鼠移植性肝癌模型并随机分为四组,分别经肝动脉灌注生理盐水(NS,1.5ml/kg)、蜂毒素(Melittin,0.35mg/kg)、空白微球(B-MS,10mg/kg)和蜂毒素-聚乳酸/羟乙酸微球(10mg/kg).比较治疗后各组大鼠的肿瘤生长情况、肿瘤坏死程度和生存时间.结果:与生理盐水组比较,Melittin组、B-MS组肿瘤生长受到明显抑制(P<0.01),肿瘤坏死程度以轻中度为主,但两组动物生存时间均未能明显延长(P>0.05).M-MS组与NS组、Melittin组及B-MS组相比,肿瘤生长抑制显著(P<0.01),肿瘤坏死更广泛、更彻底,且经蜂毒素微球治疗的大鼠生存期显著延长(P<0.01).结论:蜂毒素以药物微球的剂型经肝动脉给药,抗肿瘤效果明显优于单纯的蜂毒素和空白微球. 相似文献
8.
9.
复方盐酸伪麻黄碱缓释片的研究 总被引:1,自引:0,他引:1
应用反相HPLC法测定血药浓度,对复方盐酸伪麻黄碱缓释片的体外溶出及兔灌服一次的药物动力学进行了研究,并与自制普通片进行对照。结果表明缓释片维持体内有效血药浓度的时间较长,其相对生长利用度为122.48%。体内外显著相关。理论值与实测值基本相符。 相似文献
10.
阿霉素磁性明胶微球的研究 总被引:2,自引:0,他引:2
报告了阿霉素磁性明胶微球(Adr-MG-ms)的制备与性质,研究了超细氧化铁粒子的合成和磁性明胶微球(MG-ms)在狗体内的栓塞效果。阿霉素磁性明胶微球由2%阿霉素(Adr)、68%明胶和30%的磁铁粒子组成,微球的平均粒径为22μm。在体外实验中,药物释放速度证明微球有缓释的性质。磁铁粒子的平均粒径约为10nm,磁性明胶微球与 ̄(99m)Tc标记磁性明胶微球通过导管分别输入狗的肝动脉内进行栓塞,照相和血管造影显示在未加外磁场时磁性明胶微球在左右肝叶分布几乎相等,而在1200高斯的外磁场作用下,靶部位肝左叶的微球分布是肝右叶的2.25倍,而甲状腺、脑、心脏的微球很微量,结果表明磁性明胶微球在外磁场作用下是一个很好的治疗肝癌的栓塞剂。 相似文献